Currently Chief Executive and Board member of Ireland's National Institute for Bioprocessing Research and Training. Chairman of The Health Research Board, Ireland, (to June 2012), board member of companies in Ireland and Chairman of Excelsyn Ltd., Newcastle, UK, a leading supplier of active intermediates to the pharmaceutical industry, until it's sale to AMRI of the US in 2010. In addition, Dr. Shaw acts as consultant to various world leading companies, including Veolia and serves on various Irish Government agencies, and business groups. From 1999 to 2007, as Managing Director of Wyeth, Ireland, he had overall responsibility for one of the world's largest biotech facilities from initial design through sustaining operations in Dublin, Ireland. Prior to 1999, he was Senior VP and director for SmithKline's worldwide operations, involving 26 facilities in 11 countries. He graduated from University College, Galway in 1974 with a Ph.D. in Physical Chemistry and is a Fellow of The Institute of Chemistry of Ireland and a Fellow of The Irish Academy of Engineering. He was a member of the Government appointed Enterprise Strategy Group in 2004, and served on the Science and Technology Council. He was a board member of The American Chamber of Commerce and The Irish Bio Industry Association. He was regional President and board member of IBEC. He also was a board member of an educational institute and a treasurer for Cork Chamber of Commerce. Currently acts as an Advisory member for a Science Park in Cork. He is married with two sons and interests include music, golf, travel and photography.
Dr. Reg Shaw
@PPI_Ignite_DCU @DerekCStewart @PPI_NUIG @coileain @NicolaGaynor1 Critical to embrace PPI to understand how it can enrich our research and the way we communicate our findings @hrbireland @nicb_dcu @DcuBiotech @DCU_Cancer